MARY WALTER: Open Payments
NPI 1881370971 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $141 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $26 |
| Amgen Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Averitas Pharma Inc. | 1 | $15 |
Products named: MOUNJARO, JARDIANCE, Veozah, EVENITY, VRAYLAR, AREXVY, Ozempic, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
